Valacyclovir-induced seizures in end-stage renal disease [1]

Annals of Pharmacotherapy

Volumn 37, Issue 12, 2003, Pages 1913-

  Rivkin, Anastasia M ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMLODIPINE; CALCIUM ACETATE; GLIPIZIDE; LEVOTHYROXINE; METOPROLOL; PARICALCITOL; PHENYTOIN; RECOMBINANT ERYTHROPOIETIN; SILDENAFIL; VALACICLOVIR;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; EMERGENCY WARD; HERPES ZOSTER; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; SEIZURE;

EID: 0344844496     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D175     Document Type: Letter

References (5)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
2. Izzedine H, Mercadal L, Aymard G, Launay-Vacher V, Martinez V, Issad B, et al. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study. Am J Nephrol 2001;21:162-4.
3. Linssen-Schuurmans CD, van Kan EJ, Feith GW, Uges DR. Neurotoxicity caused by valacyclovir in a patient on hemodialysis. Ther Drug Monit 1998;20:385-6.
4. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Iwasawa H, Nanri K, et al. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 2002;58:168-70.
5. Banes D. Valacyclovir neurotoxicity: two case reports and a review of the literature. Can J Hosp Pharm 2002;55:123-7.